Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Natoni

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Cellular and Molecular Medicine|November 13, 2010
Targeting AML through DR4 with a novel variant of rhTRAILEva Szegezdi, Carlos R Reis, Almer M van der Sloot, et al.
Cancers|April 13, 2023
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated CytotoxicityAlessandro Natoni, Marina Cerreto, Maria Stefania De Propris, et al.
Oncoimmunology|February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosisSerika D Naicker, Claire L Feerick, Kevin Lynch, et al.
Blood|July 26, 2014
The sialyltransferase ST3GAL6 influences homing and survival in multiple myelomaSiobhan V Glavey, Salomon Manier, Alessandro Natoni, et al.
Cytometry. Part B, Clinical Cytometry|January 10, 2022
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysisKah Teong Soh, Neil Came, Gregory E Otteson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Cellular and Molecular Medicine|November 13, 2010
Targeting AML through DR4 with a novel variant of rhTRAILEva Szegezdi, Carlos R Reis, Almer M van der Sloot, et al.
Cancers|April 13, 2023
Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated CytotoxicityAlessandro Natoni, Marina Cerreto, Maria Stefania De Propris, et al.
Oncoimmunology|February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosisSerika D Naicker, Claire L Feerick, Kevin Lynch, et al.
Blood|July 26, 2014
The sialyltransferase ST3GAL6 influences homing and survival in multiple myelomaSiobhan V Glavey, Salomon Manier, Alessandro Natoni, et al.
Cytometry. Part B, Clinical Cytometry|January 10, 2022
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysisKah Teong Soh, Neil Came, Gregory E Otteson, et al.
Pageof 3